Gene-specific treatment approaches in muscle diseases

Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful tran...

Full description

Saved in:
Bibliographic Details
Published inNervenarzt Vol. 91; no. 4; pp. 318 - 323
Main Authors Lehmann Urban, Diana, Schneider, Ilka
Format Journal Article
LanguageGerman
Published Germany 01.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful translation of the antisense oligonucleotide (ASO) technology into clinical practice, with gene-specific ASOs being approved for the first time in 2016 for the treatment of spinal muscular atrophy and Duchenne muscular dystrophy. This article reviews recent developments in the field of antisense and gene therapies for hereditary muscle diseases.
AbstractList Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be decrypted using molecular genetic techniques, paving the way for disease-modifying treatment options. A milestone was undoubtedly the successful translation of the antisense oligonucleotide (ASO) technology into clinical practice, with gene-specific ASOs being approved for the first time in 2016 for the treatment of spinal muscular atrophy and Duchenne muscular dystrophy. This article reviews recent developments in the field of antisense and gene therapies for hereditary muscle diseases.
Author Lehmann Urban, Diana
Schneider, Ilka
Author_xml – sequence: 1
  givenname: Diana
  surname: Lehmann Urban
  fullname: Lehmann Urban, Diana
  email: diana.lehmann@rku.de
  organization: Neurologische Universitätsklinik, Universitäts- und Rehabilitationskliniken Ulm, Oberer Eselsberg 45, 89081, Ulm, Deutschland. diana.lehmann@rku.de
– sequence: 2
  givenname: Ilka
  surname: Schneider
  fullname: Schneider, Ilka
  organization: Neurologie Klinikum St. Georg, Leipzig, Deutschland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32076754$$D View this record in MEDLINE/PubMed
BookMark eNo1jz1PwzAYhC0Eoh_wBxhQRhbDObbreEQVFKRKLDBHrvNaBCVpyJsM_HsiUaa74dGju5U4744dCXGjcK8A98CAUlYihwQKB1mciaUyWksYuIVYMX9hBh1wKRY6h9s4a5bC7qgjyT3FOtUxGwcKY0vdmIW-H44hfhJndZe1E8eGsqpmCkx8JS5SaJiuT7kWH89P79sXuX_bvW4f97JXRo0yWV0YH4qQkvcbDZqLiR6pSAn5weUqWGUCNFXmYKOpKjh461VMuYJKei3u_rzzlu-JeCzbmiM1TejoOHGZa-sNYGb5Wtye0OnQUlX2Q92G4af8v6p_AVh2VUc
ContentType Journal Article
DBID NPM
7X8
DOI 10.1007/s00115-020-00870-8
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Genspezifische Therapieansätze bei Muskelerkrankungen
EISSN 1433-0407
EndPage 323
ExternalDocumentID 32076754
Genre English Abstract
Journal Article
Review
GroupedDBID -5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
29M
29~
2J2
2JN
2JY
2KG
2LR
2P1
2VQ
2~H
30V
3O-
4.4
406
408
409
40D
40E
53G
5GY
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADQRH
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M4Y
MA-
N2Q
N9A
NB0
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
OAM
P9S
PF0
PT4
QOK
QOR
QOS
R89
R9I
RIG
ROL
RPX
RRX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
X7J
YLTOR
Z45
ZGI
ZMTXR
ZOVNA
~S-
7X8
ID FETCH-LOGICAL-p141t-f53849a8aff99630eaff4c90f8ff02b721a514a03ed4b5c4dd0709591cf2101f3
IngestDate Fri Oct 25 22:21:55 EDT 2024
Wed Oct 16 00:45:17 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Cell-based treatment
Antisense oligonucleotide
Gene therapy
Myotonic dystrophy 1
Muscular dystrophy, Duchenne
Language German
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p141t-f53849a8aff99630eaff4c90f8ff02b721a514a03ed4b5c4dd0709591cf2101f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
PMID 32076754
PQID 2359400496
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2359400496
pubmed_primary_32076754
PublicationCentury 2000
PublicationDate 2020-Apr
20200401
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-Apr
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Nervenarzt
PublicationTitleAlternate Nervenarzt
PublicationYear 2020
SSID ssj0007700
Score 2.250746
SecondaryResourceType review_article
Snippet Gene-specific treatment for hereditary muscle diseases has made great progress in recent years. The pathomechanisms of many of these diseases could be...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 318
Title Gene-specific treatment approaches in muscle diseases
URI https://www.ncbi.nlm.nih.gov/pubmed/32076754
https://search.proquest.com/docview/2359400496
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA46QfYi3p03Kvg2ImmTrs2jt6Gie9HB3kaaJkx03djlxV_vSdJ2FR2oL6Wko2X52i_ntN93DkLnccxYFNEIExpJzKjiWMhEY-23FJNa0FRYlW-ndddlD72wt-iZad0ls-RCfvzoK_kPqjAGuBqX7B-QLU8KA7AP-MIWEIbtrzA2NaOx8UoavU9VM54XCrdiq-ZwPpXGHuU-xUyr4WjH6h3F5KMUvzyqwVBkWbM7Sdyr0Ru4f0rqfpaDzBTGsjDfv7-J6kuDgFS0JsoRHaMUBl3H2YIJXd-sHHFWoTXqOPIb3TqFhe1eZnzexqMOzz_-8mOYsvHQAkADYkrHsMXSUwoCi0OraC0AxohraO2yfXXVKRfVKCIk9zxZ5-O3S9bRenGS5cmCDRpeNtFGHu17lw66LbSSqm20_pTrGXZQ-AVBr0TQWyDovWaeQ9ArENxF3fbty_UdzhtZ4LHP_BnWsKowLmKhNaSXlCjYYZITHWtNggSScAFxqyBUpSwJJUtTIGIecl9qyMh9TfdQLRtl6gB53NfcNFVViUiZjGIeiwRCPq19HUImKRrorPjvfSAK8_VHZGo0n_YDGnJD2LzVQPtuUvpjV9GkX8zc4dIjR6i-uI-OUW02masTCMdmyWkO1SfAqTKO
link.rule.ids 315,783,787,27938,27939
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gene-specific+treatment+approaches+in+muscle+diseases&rft.jtitle=Nervenarzt&rft.au=Lehmann+Urban%2C+Diana&rft.au=Schneider%2C+Ilka&rft.date=2020-04-01&rft.eissn=1433-0407&rft.volume=91&rft.issue=4&rft.spage=318&rft_id=info:doi/10.1007%2Fs00115-020-00870-8&rft_id=info%3Apmid%2F32076754&rft.externalDocID=32076754